Last 5,740 INR
Change Today -133.05 / -2.27%
Volume 1.8K
SKB On Other Exchanges
Symbol
Exchange
Natl India
As of 12:36 AM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

glaxosmithkline consumer hea (SKB) Snapshot

Open
5,870
Previous Close
5,873
Day High
5,870
Day Low
5,720
52 Week High
11/25/14 - 5,999
52 Week Low
03/12/14 - 4,011
Market Cap
241.4B
Average Volume 10 Days
9.0K
EPS TTM
--
Shares Outstanding
42.1M
EX-Date
07/28/14
P/E TM
--
Dividend
45.00
Dividend Yield
0.78%
Current Stock Chart for GLAXOSMITHKLINE CONSUMER HEA (SKB)

Related News

No related news articles were found.

glaxosmithkline consumer hea (SKB) Related Businessweek News

No Related Businessweek News Found

glaxosmithkline consumer hea (SKB) Details

GlaxoSmithKline Consumer Healthcare Limited operates in the health food drinks industry in India. It manufactures and markets health food drinks, nutritional supplements, biscuits, and choco-malt drinks under the Horlicks, Boost, Maltova, and Viva brand names. The company also offers over-the-counter medicine, including Crocin, a pain and body ache relieving drug; Crocin Pain Relief, a pain relief medicine; Crocin Cold and Flu, which provides relief from cold; and Crocin paediatric medicines for infants, toddlers, and older kids up to 12 years. In addition, it provides Eno, an antacid for acidity, gastric discomfort, and heat burn; and Iodex for head, neck, back joint, and muscular pains, as well as Iodex creams and gels; and oral care products under the Sensodyne brand name. The company exports its products to Pakistan, Myanmar, Sri Lanka, Bangladesh, the Middle East, Nepal, Kenya, and Malaysia. GlaxoSmithKline Consumer Healthcare Limited was incorporated in 1958 and is headquartered in Gurgaon, India.

3,502 Employees
Last Reported Date: 07/11/14
Founded in 1958

glaxosmithkline consumer hea (SKB) Top Compensated Officers

Managing Director, Senior Vice President of I...
Total Annual Compensation: 97.4M
Director of Finance, Wholetime Director, Memb...
Total Annual Compensation: 36.7M
Director of Operations, Wholetime Director an...
Total Annual Compensation: 36.4M
Compensation as of Fiscal Year 2014.

glaxosmithkline consumer hea (SKB) Key Developments

GlaxoSmithKline Consumer Healthcare Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

GlaxoSmithKline Consumer Healthcare Limited reported unaudited standalone earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported net sales/income from operations was INR 10,746.6 million against INR 9,719.4 million a year ago. Total income from operations (net) was INR 11,136.0 million against INR 1,014.08 million for the same period a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,835.8 million against INR 1,804.5 million for the same period a year ago. Profit from ordinary activities before tax was INR 2,452.5 million against INR 2,237.0 million for the same period a year ago. Net profit for the period was INR 1,602.9 million against INR 1,469.3 million for the same period a year ago. Basic and diluted earnings (before and after extraordinary items) were INR 38.11 per share against INR 34.93 per share a year ago. For the nine months, net sales/income from operations was INR 19,962.1 million against INR 27,647.2 million a year ago. Total income from operations (net) was INR 20,795.7 million against INR 28,797.6 million for the same period a year ago. Profit from operations before other income, finance costs and exceptional items was INR 3,363.1 million against INR 5,198.9 million for the same period a year ago. Profit from ordinary activities before tax was INR 4,435.5 million against INR 6,338.1 million for the same period a year ago. Net profit for the period was INR 2,904.1 million against INR 4,233.0 million for the same period a year ago. Basic and diluted earnings (before and after extraordinary items) were INR 69.05 per share against INR 100.64 per share a year ago.

GlaxoSmithKline Consumer Healthcare Limited, Q2 2015 Earnings Call, Nov 06, 2014

GlaxoSmithKline Consumer Healthcare Limited, Q2 2015 Earnings Call, Nov 06, 2014

GlaxoSmithKline Consumer Healthcare Limited to Report Q2, 2015 Results on Nov 05, 2014

GlaxoSmithKline Consumer Healthcare Limited announced that they will report Q2, 2015 results on Nov 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKB:IN 5,739.95 INR -133.05

SKB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $4.14 USD 0.00
DC Brands International Inc $0.0001 USD 0.00
Perrigo Co PLC $156.47 USD -0.42
VIVUS Inc $3.32 USD -0.08
View Industry Companies
 

Industry Analysis

SKB

Industry Average

Valuation SKB Industry Range
Price/Earnings 45.8x
Price/Sales 6.1x
Price/Book 11.8x
Price/Cash Flow 41.8x
TEV/Sales 5.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE CONSUMER HEA, please visit www.gsk-ch.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.